I want to thank you and the Ranking Member for holding a very important hearing.

You have constituents right now who on a Friday when their physician's office is independently owned were paying a couple hundred dollars for a treatment. And on Monday, after the hospital buys it, it can go up to $1,000.

In the Inflation Reduction Act, we took on big pharma by finally allowing Medicare to negotiate prescription drug prices.

In the Inflation Reduction Act, we took on big pharma by finally allowing Medicare to negotiate prescription drug prices.

You have constituents right now who on a Friday when their physician's office is independently owned were paying a couple hundred dollars for a treatment. And on Monday, after the hospital buys it, it can go up to $1,000.

Can you elaborate on what those steps would be?

It should not matter where the funding comes from in terms of making sure this research is being done safely, securely, and responsibly.

Thank you. Thank you, Mr. Chair.

In order to expand the scope of oversight to all privately funded research would require a legislative action.

Thank you, Chair Peters, and Ranking Member Paul for holding this hearing.

In order to expand the scope of oversight to all privately funded research would require a legislative action.

Can you elaborate on what those steps would be?

Thank you. Thank you, Mr. Chair.

It should not matter where the funding comes from in terms of making sure this research is being done safely, securely, and responsibly.

Thank you, Chair Peters, and Ranking Member Paul for holding this hearing.

I look forward to continuing to collaborate with my colleagues on this important effort.

Thank you, Chair Sanders. And thanks to all of you for being here. It's a very interesting and important and timely conversation.

I've heard from some stakeholders who say WIOA reporting requirements are overly burdensome.